Non-prescription and compounded peptides such as BPC-157, CJC-1295/Ipamorelin, AOD-9604, and MOTS-c are not FDA-approved for weight loss and lack the same regulatory oversight and clinical safety data as the GLP-1 drugs in the table above, which is why they should only be used under the guidance of a licensed medical provider who can order lab work, personalize dosing, and monitor for side effects throughout treatment
This clinical study with NAD+ IV infusion demonstrates improved depression and anxiety symptoms in 50 individuals with cravings and addictive behaviors.
Those with severe deficiencies may receive more frequent doses at first before tapering frequency
It minimizes the appearance of imperfections gently and safely as it softens fine lines and wrinkles, reduces discoloration, minimizes sagginess, and help restore some of the skins natural ability to resist damage
rztd or Rttrutd for combined metabolic modulation and fat loss
These can be reviewed by here